Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2007, Vol. 109, No. 3, pp. 1131-1137.
Prepublished online as a Blood First Edition Paper on September 19, 2006; DOI 10.1182/blood-2006-05-023770.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-05-023770v1
109/3/1131    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cervantes-Barragan, L.
Right arrow Articles by Ludewig, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cervantes-Barragan, L.
Right arrow Articles by Ludewig, B.
Related Collections
Right arrow Immunobiology
Right arrow Phagocytes
Right arrow Chemokines, Cytokines, and Interleukins
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon

Luisa Cervantes-Barragan1,2, Roland Züst1, Friedemann Weber3, Martin Spiegel3, Karl S. Lang4, Shizuo Akira5, Volker Thiel1, and Burkhard Ludewig1

1 Research Department, Kantonal Hospital St Gallen, St Gallen, Switzerland; 2 Unidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades, Mexico City, Mexico; 3 Abteilung Virologie, Institut fur Medizinische Mikrobiologie und Hygiene, Universitat Freiburg, Freiburg, Germany; 4 Institute of Experimental Immunology, University Hospital, Zurich, Switzerland; 5 Department of Host Defense, Osaka University, Osaka, Japan

This study demonstrates a unique and crucial role of plasmacytoid dendritic cells (pDCs) and pDC-derived type I interferons (IFNs) in the pathogenesis of mouse coronavirus infection. pDCs controlled the fast replicating mouse hepatitis virus (MHV) through the immediate production of type I IFNs. Recognition of MHV by pDCs was mediated via TLR7 ensuring a swift IFN-{alpha} production following encounter with this cytopathic RNA virus. Furthermore, the particular type I IFN response pattern was not restricted to the murine coronavirus, but was also found in infection with the highly cytopathic human severe acute respiratory syndrome (SARS) coronavirus. Taken together, our results suggest that rapid production of type I IFNs by pDCs is essential for the control of potentially lethal coronavirus infections.

Abbreviations: MHV, indicates mouse hepatitis virusSARS, severe acute respiratory syndromepDCs, plasmacytoid dendritic cellscDCs, conventional dendritic cells


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
K. Narayanan, C. Huang, K. Lokugamage, W. Kamitani, T. Ikegami, C.-T. K. Tseng, and S. Makino
Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells
J. Virol., May 1, 2008; 82(9): 4471 - 4479.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Tekes, R. Hofmann-Lehmann, I. Stallkamp, V. Thiel, and H.-J. Thiel
Genome Organization and Reverse Genetic Analysis of a Type I Feline Coronavirus
J. Virol., February 15, 2008; 82(4): 1851 - 1859.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Ank, M. B. Iversen, C. Bartholdy, P. Staeheli, R. Hartmann, U. B. Jensen, F. Dagnaes-Hansen, A. R. Thomsen, Z. Chen, H. Haugen, et al.
An Important Role for Type III Interferon (IFN-{lambda}/IL-28) in TLR-Induced Antiviral Activity
J. Immunol., February 15, 2008; 180(4): 2474 - 2485.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. D. C. Ireland, S. A. Stohlman, D. R. Hinton, R. Atkinson, and C. C. Bergmann
Type I Interferons Are Essential in Controlling Neurotropic Coronavirus Infection Irrespective of Functional CD8 T Cells
J. Virol., January 1, 2008; 82(1): 300 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. J. Robertson, C. G. Ammann, R. J. Messer, A. B. Carmody, L. Myers, U. Dittmer, S. Nair, N. Gerlach, L. H. Evans, W. A. Cafruny, et al.
Suppression of Acute Anti-Friend Virus CD8+ T-Cell Responses by Coinfection with Lactate Dehydrogenase-Elevating Virus
J. Virol., January 1, 2008; 82(1): 408 - 418.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. Zucchini, G. Bessou, S. H. Robbins, L. Chasson, A. Raper, P. R. Crocker, and M. Dalod
Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection
Int. Immunol., January 1, 2008; 20(1): 45 - 56.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. G. Devaraj, N. Wang, Z. Chen, Z. Chen, M. Tseng, N. Barretto, R. Lin, C. J. Peters, C.-T. K. Tseng, S. C. Baker, et al.
Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus
J. Biol. Chem., November 2, 2007; 282(44): 32208 - 32221.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. J. Cameron, L. Ran, L. Xu, A. Danesh, J. F. Bermejo-Martin, C. M. Cameron, M. P. Muller, W. L. Gold, S. E. Richardson, S. M. Poutanen, et al.
Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome
J. Virol., August 15, 2007; 81(16): 8692 - 8706.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. K. Roth-Cross, L. Martinez-Sobrido, E. P. Scott, A. Garcia-Sastre, and S. R. Weiss
Inhibition of the Alpha/Beta Interferon Response by Mouse Hepatitis Virus at Multiple Levels
J. Virol., July 1, 2007; 81(13): 7189 - 7199.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
U. Schleicher, J. Liese, I. Knippertz, C. Kurzmann, A. Hesse, A. Heit, J. A.A. Fischer, S. Weiss, U. Kalinke, S. Kunz, et al.
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs
J. Exp. Med., April 16, 2007; 204(4): 893 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Zhou and S. Perlman
Mouse Hepatitis Virus Does Not Induce Beta Interferon Synthesis and Does Not Inhibit Its Induction by Double-Stranded RNA
J. Virol., January 15, 2007; 81(2): 568 - 574.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020